Canopy Growth Corp. (TSX:WEED) Stock Could Hit Triple Digits This Year

Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) has managed to meet high expectations so far and the stock is well on its way to a triple-digit valuation.

| More on:
Arrowings ascending on a chalkboard

Image source: Getty Images.

Canopy Growth (TSX:WEED)(NYSE:CGC) stock threatened its all-time high in late January before retreating in early February. The stock was still up 67% in 2019 as of close on February 14. Its high valuation was one of the reasons I’d warned investors about jumping into cannabis stocks at this juncture.

The cannabis sector has enjoyed success to kick off 2019 and has been a big factor in propelling the TSX to its best start to a year in decades. Canopy Growth’s stock pop in late January was influenced by a rave report from Canadian Imperial Bank of Commerce. “We believe that Canopy Growth represents the industry’s best chance at a global titan,” the report stated.

On the day of recreational legalization, I’d explained why Canopy Growth was the strongest and most dependable producer for the young industry. Canopy Growth had achieved this through top flight management and sound spending. It’s fitting that a Canopy Growth-owned retailer also sold the first cannabis product when the clock struck midnight on October 17, 2018.

Canopy Growth released its fiscal 2019 third-quarter results after markets closed on February 14. Revenues surged 256% year-over-year to $83 million on the back of 10,102 kilograms in cannabis or its oil equivalent sales. Canopy reported net income of $74.8 million or $0.22 per share after a $330 million loss in the prior quarter. However, the company had reiterated that this loss was largely due to spiking operating expenses in preparation for legalization.

Early data showed that recreational sales were slow out of the gate. This should come as no surprise given the myriad issues covered over the course of the rollout. These included supply shortages, logistical problems, and delayed opening of retail stores that continues to this day. Ontario has been especially slow on the draw, and as of today there are still no licensed brick-and-mortar retails active in the nation’s largest province.

The recreational market accounted for over 70% of Canopy’s cannabis sales, which is a promising result with other producers still heavily reliant on the medical market. Like its peers, Canopy is looking to expand internationally in order to fuel growth going forward. The company has begun to tiptoe into the U.S. market after the passage of legislation that removed hemp-derived cannabidiol from the Controlled Substances Act.

Back in November 2018, Canopy revealed that it would spend more than $115 million over the next two years to expand production in the European Union. Cannabis legalization is moving quickly in the European Union in comparison to the slow-moving battle underway south of the border. On February 13, the European Parliament voted on a resolution that would help advance medical cannabis legalization for its member states.

So how does Canopy’s value look right now? What are the chances it breaches the $100 mark in 2019? As of close on February 14, the stock had an RSI of 57, as shares have fallen out of overbought territory. The cannabis sector has been historically volatile, but Canopy Growth is setting itself apart by expanding its global reach. With results to back up the hype, Canopy Growth is a great bet to reach the triple-digit milestone this year.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned.

More on Bank Stocks

stock analysis
Dividend Stocks

Meta Is Now a Dividend Stock, but This TSX Stock Is a Better Buy

Social media giant Meta is now a dividend payer but a TSX stock is a better buy for its 156-year…

Read more »

Man making notes on graphs and charts
Bank Stocks

TD Bank: Should You Buy the Dip?

TD is down about 8% in 2024. Is the stock now oversold?

Read more »

edit Four girl friends withdrawing money from credit card at ATM
Bank Stocks

2 Top TSX Bank Stocks to Buy if There’s Another Stock Market SellOff

Here are two of the most attractive Canadian bank stocks you can consider buying if there is another stock market…

Read more »

Mature financial advisor showing report to young couple for their investment
Bank Stocks

Why Goeasy Stock Rose 4.4% on Monday

Operating results out of goeasy have continued strong, and this, combined with the stock's low valuation, is gaining investors' interest.

Read more »

Senior couple at the lake having a picnic
Bank Stocks

Could Royal Bank Stock Help You Retire a Millionaire?

Let's dive into whether Royal Bank stock could be the best way for investors to retire millionaires, given its historical…

Read more »

Bank sign on traditional europe building facade
Bank Stocks

Canadian Bank Stocks: Buy, Sell, or Hold?

Canadian bank stocks are recovering, but high interest rates will still impact them for the next year. However, this one…

Read more »

Early retirement handwritten in a note
Bank Stocks

3 Reasons NOT to Claim CPP Benefits at Age 60

If you hold large amounts of Toronto-Dominion Bank (TSX:TD) stock, you may not need to take CPP at 60.

Read more »

question marks written reminders tickets
Bank Stocks

Better Buy: CIBC or Bank of Nova Scotia Stock?

If you focus more on dividend yield than capital appreciation potential, one Canadian bank may better fit you than others.

Read more »